NCT03436914View on ClinicalTrials.gov

Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

October 18, 2019

Study Completion Date

October 18, 2019

Conditions
Non-erosive Gatroesophageal Reflux Disease
Interventions
DRUG

PPI

After the diagnosis of NERD through patient's symptom and endoscopy, PPI (esomezol) will be given for 8 weeks. The effect of PPI for NERD patients will be analyzed.

Trial Locations (1)

03722

Yonsei university College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03436914 - Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease | Biotech Hunter | Biotech Hunter